MedPath

Management of Janusandhigata Vata (Knee Joint Osteoarthritis) With Upanaha and Physiotherapy (Ultrasound)

Phase 4
Completed
Conditions
Osteoarthritis of knee, unspecified, (2) ICD-10 Condition: M171||Unilateral primary osteoarthritisof knee,
Registration Number
CTRI/2020/07/026267
Lead Sponsor
Shri BMK Ayurveda MahavidyalayaPost Graduate Studies and Research Center
Brief Summary

Osteoarthritis has high prevalence, especially in the elderly, and thehigh rate of disability related to disease makes it a leading cause ofdisability in the elderly.  In the UnitedStates, osteoarthritis prevalence will increase from 66–100% by the year 2020

Sandhigatavata can be compared with Osteoarthritis of contemporarymedical science. Osteoarthritis is the second largest musculoskeletal disorderin the world (30%) after low back pain (50%). The reported prevalence ofOsteoarthritis from a study in rural India is 5.78%

The hip and knee are the principle large joints affected and are theprinciple sites of significant disability. Knee osteoarthritis is more prevalentthan hip osteoarthritis, but taken together they affect 10-25 % of those agedover 65years.

Sandhigatavata is one of vatavyadhi explained in ourclassics, in which swelling, painful movements of the joints are seen. It is treated “Snehana,swedan,upanaha,agnikarma,bandhana, mardan’’,Raktamokshana, matrabasti nirgundi patrapindasweda,which areemphasized to provide better relief of painand swelling and to restore the mobility.

Upanaha swedana is used in vatavyadhi which relivesshula (pain), sankoca(restricted movement), and stambha (stiffness)

Ultra sonic therapy was   introduced into the United States in 1949after establishing its reputation as an efficient therapeutic modality in Europe.A British study in 1954, based on a tabulation of 100,000 cases, reportedexcellent results of its use in 60-70 percent of cases of arthritis.

Ultrasound demonstrates the ability to evoke abroad range of therapeutically beneficial effects which may provide safe andeffective applications in the management of osteoarthritis.

Hence this studyattempts to determine the effect of two different forms of therapies that is upanahaand ultrasound in Janusadhigatavata (osteoarthritis of knee joints).

---

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
45
Inclusion Criteria

Patient presenting with classical signs and symptoms of Janusandhigatvata like vatapurnadrithisparshansopham (swelling), prasaranaakunchanyovedanam (pain on extension andflexion movement) and sandhigraham (restricted range of movements).

Exclusion Criteria
  • 1.Patients showing signs and symptoms of gout, rheumatoid arthritis.
  • 2.Acute joint trauma.
  • 3.Complete loss of articular cartilage.
  • 4.Known case of skin allergy and open wound.
  • 5.Pitta associated with signs and symptoms like: daha, raga and ushma 6.Samavata condition 7.Pregnant women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Group A(15 Patients) treated with Upanaha may have relief up t0 60-70 percentage, Group B(15 patients) treated with Ultrasound may have relief 50-60 percentage and Group C (15 patients) Treated with combined therapy patient may have relief upto 70-80% percentageResults will outcome in 7 days.
Secondary Outcome Measures
NameTimeMethod
group A, Group B, Group C where patients may be reduction of pain ,Stiffness, Difficulties, reduction knee joint swelling, reduction of Tenderness and improved Range of motion by 50-80 %.total duration 7 days

Trial Locations

Locations (1)

K L E U s Shri B M K Ayurveda Mahavidyalaya Post Graduate Studies and Research Center

🇮🇳

Belgaum, KARNATAKA, India

K L E U s Shri B M K Ayurveda Mahavidyalaya Post Graduate Studies and Research Center
🇮🇳Belgaum, KARNATAKA, India
DR Arun Kumar Gupta
Principal investigator
8989243480
arungupta.5983@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.